Copyright: ©Author(s) 2026.
World J Hepatol. Mar 27, 2026; 18(3): 113284
Published online Mar 27, 2026. doi: 10.4254/wjh.v18.i3.113284
Published online Mar 27, 2026. doi: 10.4254/wjh.v18.i3.113284
Figure 1 Pathophysiology of metabolically associated fatty liver disease development.
T2DM: Type 2 diabetes mellitus; HCC: Hepatocellular carcinoma.
- Citation: Plakida A, Iushkovska O, Sierpińska LE. Metabolically associated fatty liver disease: What hepatologists need to know about this systemic disease. World J Hepatol 2026; 18(3): 113284
- URL: https://www.wjgnet.com/1948-5182/full/v18/i3/113284.htm
- DOI: https://dx.doi.org/10.4254/wjh.v18.i3.113284
